MARKET

XPH

XPH

SPDR® S&P Pharmaceuticals ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

48.32
-0.04
-0.08%
Opening 10:36 09/24 EDT
OPEN
48.32
PREV CLOSE
48.36
HIGH
48.32
LOW
48.32
VOLUME
1.97K
TURNOVER
--
52 WEEK HIGH
56.32
52 WEEK LOW
42.22
TOTAL ASSET
235.33M
YTD YIELD
-4.44%
1D
5D
1M
3M
1Y
5Y
Evergrande Blowup Ensnares Stocks With Very Little Link to China
Bloomberg · 3d ago
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0892
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - $0.0892. 30-Day SEC Yield of 0.66% as of Sept. 17. Payable Sep 23; for shareholders of record Sep 21; ex-div Sep 20.
Seekingalpha · 3d ago
Wall Street Traders Were All Hedged Up for Volatility Like This
Bloomberg · 3d ago
Nomura Quant Warns of $40 Billion Selling by Volatility Funds
Bloomberg · 4d ago
Bristol Myers stock falls toward 6-month low, set to suffer longest losing streak in 3 1/2 years
Shares of Bristol Myers Squibb Co. slumped 1.7% in midday trading Thursday toward a six-month low, putting them on track to suffer the longest losing streak in 3 1/2 years. The stock is headed for a ninth-straight loss, and has declined 7.8% during that st...
Marketwatch.com · 09/16 16:54
Pharma ETFs Gain on Q2 Earnings
Zacks.com · 08/06 14:05
Lionsbridge Wealth Management LLC Buys ProShares Short S&P500, Global X U.S. ...
GuruFocus News · 07/29 22:38
Common cholesterol drugs may lower death risk from COVID-19
rogerashford/iStock via Getty Images Statins, a popular class of cholesterol-lowering drugs, may also lower the risk of death from COVID-19, according to new findings. Examining data from the American Heart
Seekingalpha · 07/20 03:09
More
No Data
Learn about the latest financial forecast of XPH. Analyze the recent business situations of SPDR® S&P Pharmaceuticals ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-2.1617%
--
1-Week
0.0432%
--
1-Month
-0.3793%
--
3-Month
0.4992%
--
6-Month
5.0086%
--
YTD
-4.4365%
--
1-Year
25.1785%
--
3-Year
1.2186%
--
5-Year
-3.5232%
--
10-Year
9.8792%
--
Since Inception
9.4359%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
SPDR® S&P Pharmaceuticals ETF
Risk
Medium-high risk
Inception Date
2006-06-19
Benchmark
Dow Jones US Healthcare TR
Advisor Company
State Street Global Advisors Ltd
Custodian
State Street Bank & Trust Co
Manager
Feehily/Schneider/Richardson